Rigel Pharmaceuticals RIGL Accrued commercial expenses
Accrued commercial expenses at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept rigl:AccruedCommercialExpensesCurrent.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's accrued commercial expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's accrued commercial expenses?
- Rigel Pharmaceuticals (RIGL) reported accrued commercial expenses of $2.19M in Q4 2025.
- What does accrued commercial expenses mean?
- This includes liabilities for commercial activities, such as marketing, sales commissions, or distribution costs, that have been incurred but not yet paid. It reflects the operational intensity of the company's commercialization efforts for its drug portfolio. Monitoring this helps assess the alignment between commercial spending and revenue generation.